Tag: Option Care
Option Care leans on ‘momentum of base business’ in wake of failed deal
July 28, 2023Theresa Flaherty, Managing Editor
BANNOCKBURN, Ill. – Option Care will return nearly all of a $106 million break-up fee to shareholders, as the company moves on from its failed merger with Amedisys, said CEO John Rademacher.
Option Care announced in June that it had terminated its $3.6 billion merger with Amedisys, just weeks after the two companies announced the deal.
“Given the strength of our balance sheet and forward outlook, we believe it is appropriate to return essentially all of the break fee...
In brief: Walgreens lets go of Option Care, Quantum seeks Roll Models
June 14, 2023HME News Staff
DEERFIELD, Ill. - Walgreens Boots Alliance has sold its remaining 10.8 million shares of Option Care Health, generating about $330 million.
Earlier this year, in March, Walgreens sold 13 million shares of Option Care Health at $30.75 per share. Last year, it sold 11 million shares in the company.
Walgreens says it will use the proceeds from the sale “primarily for debt paydown, continued support of the company’s strategic priorities and healthcare transformation.”
The...
Option Care nabs exclusive distribution contract for Vyjuvek
May 24, 2023HME News Staff
BANNOCKBURN, Ill. – Option Care Health has been selected by Krystal Biotech as part of a limited distribution specialty pharmacy network for Vyjuvek, which was recently approved by the U.S. Food & Drug Administration for the treatment of patients with dystrophic epidermolysis bullosa (DEB). Through its national footprint of more than 95 specialty pharmacies, Option Care will serve as the only specialty pharmacy provider for mixing and delivering prepared Vyjuvek gel administration syringes...
Option Care, Amedisys scale up
May 5, 2023Theresa Flaherty, Managing Editor
BANNOCKBURN, Ill., and BATON ROUGE, La. – The merger of Option Care Health and Amedisys creates a home care giant with projected annual revenue of $6.2 billion that’s primed to serve a $100 billion addressable market for everything from prevention and maintenance care to acute and post-acute care to end-of-life care.
Option Care, the nation's largest independent provider of home and alternate site infusion services, and Amedisys, a leading provider of home health, hospice...
In brief: Sleep patient volume, ResMed promotions, Quipt uplist
May 5, 2023HME News Staff
NEW YORK – Providers expect to see double-digit growth in their sleep patient volume over the next 12 months as flow-generator availability improves, according to the first quarter 2023 HME Sleep and Oxygen Survey from Needham.
Respondents reported that they have been able to purchase their desired flow generators within required timeframes as follows: Philips, 15.6% (up from 12.1% in Q3 2022); Fisher & Paykel, 25% (up from 9.4% in Q3 2022); and ResMed, 61.4% (up from 39.2% in Q3 2022).
The...
Option Care Health, Amedisys to merge
May 3, 2023HME News Staff
BANNOCKBURN, Ill. and BATON ROUGE, La., - Option Care Health, Inc., the nation's largest independent provider of home and alternate site infusion services, and Amedisys, Inc., a leading provider of home health, hospice and high-acuity care, have entered into an agreement to merge.
The all-stock transaction values Amedisys at approximately $3.6 billion, including the assumption of net debt.
Combining Amedisys' home health, hospice, palliative,...
In brief: AAH survey, CR modifier, Option Care network
May 3, 2023HME News Staff
WASHINGTON – AAHomecare’s strategic priorities survey is live.
The brief survey seeks input from all areas of the home medical equipment sector, including suppliers, manufacturers, distributors, service providers and association executives. It will remain open through May 12.
“Just as our health care system is changing, AAHomecare must evolve to support its wide range of stakeholders,” said Josh Marx, CEO of Medical Service Company and chairman...
NHIA announces new board chair, expands seats
March 8, 2023HME News Staff
ALEXANDRIA, Va. – Option Care CEO John Rademacher has been named chair of the board of directors for The National Home Infusion Association. He takes over from Tim Affeldt, who will transition into past chair. “We welcome John’s leadership and expertise at a critical time as the association continues to grow and diversify,” said Connie Sullivan, NHIA president and CEO. “His industry knowledge and perspective will be key advantages as NHIA advocates for appropriate payment...
In brief: Golden moves faster, transportation delays persist, AdaptHealth buys Keene
April 15, 2022HME News Staff
OLD FORGE, Pa. – Golden Technologies on April 4 decreased lead times on in-stock power lift recliners to one week and custom build orders to six weeks.
Over the last 12 months, the company says it has been working hard to expand a diverse supply chain for parts and products to ensure a continuous supply of products and services and has opened a new distribution center that spans 170,000 square feet.
“As part of our continued operational and logistics improvement...
Option Care credits new therapies, infusion suites for growth
November 12, 2021Theresa Flaherty, Managing Editor
BANNOCKBURN, Ill. – Option Care Health recorded its second straight quarter of “high-teens growth” for its chronic therapy portfolio and sees ongoing opportunity in the $100 billion market, says CEO John Rademacher.
“We did have some new therapies that were introduced that we continue to see traction on moving forward,” he said on a recent call to discuss the company’s third quarter earnings. “I think, as we have defined the market, it's $100...